by FBorchert | Nov 14, 2022 | News
ABX-CRO at TRP 2022 Meet ABX-CRO executives at the SNMMI 2022 Annual Meeting June 11-14 | Vancouver, BC, at booth no. # 649. Celebrate with us our inauguration of our Boston-based US branch ABX-CRO Inc., further strengthening our global operations, and see the latest...
by FBorchert | Jun 1, 2022 | News
ABX-CRO at SNMMI 2022 Meet ABX-CRO executives at the SNMMI 2022 Annual Meeting June 11-14 | Vancouver, BC, at booth no. # 649. Celebrate with us our inauguration of our Boston-based US branch ABX-CRO Inc., further strengthening our global operations, and see the...
by FBorchert | May 24, 2022 | News
Andreas Fintelmann, leading radiopharmaceutical and precursor industry expert and executive joins ABX-CRO as managing director to support the further global expansion and growth of ABX-CRO. Andreas Fintelmann states “I am delighted to join ABX-CRO and reunite with...
by FBorchert | Oct 28, 2021 | News
Preclinical and clinical evaluation of radiopharmaceuticals can be sometimes seen as straightforward compared to non-radioactive molecules as the injected doses are often below toxic doses. However, the development of theranostics requires highly specific expertise...
by FBorchert | Aug 31, 2021 | News
Speaking about why ABX-CRO decided to choose Flex Databases, Dr. Ulrike Schorr-Neufing said: The possibility of on-premise solutions for CTMS and eTMF as well as the flexibility of the different modules for managing clinical trials suits ABX-CRO very well. Flex...
by FBorchert | Jul 7, 2021 | News
ABX-CRO, Oncodesign, Covalab and CheMatech launch DRIVE™-MRT, a premium, complete integrated service offer for radiopharmaceuticals drug discovery and generation New integrated drug discovery offer in nuclear medicine enables specialized partners to provide...
